Dexcom Inc., US2521311074

Dexcom stock last trades at USD 86.68 on September 28, 2026

Published on 09/28/2026 at 22:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Dexcom stock last traded at USD 86.68 on September 28, 2026, up 0.07 percent. The company released a new Type 2 diabetes report and announced a Team Novo Nordisk partnership.

Fotorealistischer CGM-Sensor-Patch am Arm, klinisches Umfeld, Medizintechnik
Dexcom Inc. zeigt fotorealistischen CGM-Sensor am Unterarm für Anleger mit ISIN US2521311074 Medizintechnik, Illustration mit AI erstellt.

Dexcom Inc. stock last traded at USD 86.68 on Nasdaq on September 28, 2026, at 8:00:01 PM UTC, up 0.07 percent from the previous close of USD 86.62.

Trading session

The quote for Dexcom's common stock, traded under the ticker DXCM on the Nasdaq Global Select Market, showed a daily gain of USD 0.06. The stock data and the company's dated announcements are presented separately.

Report and partnership announced

On September 28, 2026, Dexcom said it released its 2026 State of Type 2 Report ahead of the European Association for the Study of Diabetes meeting in Milan, scheduled for September 28 through October 2. The company said the report identified health literacy, technology literacy and systemic access as interconnected challenges in Type 2 diabetes care.

Dexcom also announced a partnership with Team Novo Nordisk under which Dexcom will become the professional cycling team's official continuous glucose monitoring partner. The company said the partnership will create opportunities to advance real-world research, education and awareness related to glucose insights and Type 1 diabetes.

Disclaimer...

en | US2521311074 | DEXCOM INC. | boerse | 70195377 | bgmi